New Product: Epclusa (sofosbuvir 200 mg and velpatasvir 50 mg) film-coated tablets

This new lower strength form of Epclusa has been launched specifically for the treatment of chronic hepatitis C virus infection in patients aged 6 years and older and weighing at least 17 kg.

electronic Medicines compendium